Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | sodium channel protein | 0.0599 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0082 | 0.0271 | 0.2342 |
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.0208 | 0.2637 | 0.2316 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.0754 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.0754 | 0.6526 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0208 | 0.2637 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.0754 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.0754 | 0.6526 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0108 | 0.0754 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0129 | 0.1156 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.0754 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.0754 | 0.6526 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0108 | 0.0754 | 0.2789 |
Entamoeba histolytica | hypothetical protein | 0.009 | 0.0417 | 0.3025 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.0754 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.0754 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.0754 | 0.6526 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0108 | 0.0754 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.0754 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.0754 | 0.6526 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0108 | 0.0754 | 0.152 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0108 | 0.0754 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.0754 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.0754 | 0.6526 |
Echinococcus granulosus | DNA dependent protein kinase catalytic subunit | 0.053 | 0.8699 | 0.8642 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0108 | 0.0754 | 0.0352 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.0754 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.0754 | 0.6526 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0108 | 0.0754 | 0.6526 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0181 | 0.2122 | 0.8027 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0208 | 0.2637 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.0754 | 0.6526 |
Loa Loa (eye worm) | hypothetical protein | 0.0069 | 0.0026 | 0.0229 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0208 | 0.2637 | 1 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.0208 | 0.2637 | 0.2316 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0129 | 0.1156 | 1 |
Schistosoma mansoni | phosphatidylinositol 3-and 4-kinase | 0.0208 | 0.2637 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.0754 | 0.6526 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0108 | 0.0754 | 0.2789 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0108 | 0.0754 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.0754 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.0754 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.0754 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.009 | 0.0417 | 0.3608 |
Giardia lamblia | GTOR | 0.0108 | 0.0754 | 0.5 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0108 | 0.0754 | 0.2789 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0108 | 0.0754 | 0.152 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.0754 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.0754 | 0.6526 |
Leishmania major | phosphatidylinositol 3-related kinase, putative | 0.0129 | 0.1156 | 0.0434 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.0754 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.0754 | 0.6526 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0108 | 0.0754 | 0.6526 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.0754 | 0.6526 |
Echinococcus multilocularis | DNA dependent protein kinase catalytic subunit | 0.053 | 0.8699 | 0.8642 |
Toxoplasma gondii | FATC domain-containing protein | 0.009 | 0.0417 | 0.5528 |
Trypanosoma brucei | phosphatidylinositol kinase related protein, putative | 0.009 | 0.0417 | 0.3608 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.0754 | 0.6526 |
Leishmania major | hypothetical protein, conserved | 0.0201 | 0.2512 | 0.1901 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.0754 | 0.6526 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0108 | 0.0754 | 0.0352 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0108 | 0.0754 | 0.6526 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0108 | 0.0754 | 1 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0129 | 0.1156 | 1 |
Echinococcus granulosus | voltage gated sodium channel Nav1 alpha subunit | 0.0599 | 1 | 1 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0108 | 0.0754 | 0.6526 |
Leishmania major | calcium channel protein, putative,ion transporter, putative | 0.0599 | 1 | 1 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.009 | 0.0417 | 0.1497 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.